Quick Update: Radient Pharmaceuticals (RPC)

On 4/20/10, I posted a Quick Analysis on Radient Pharmaceuticals (RPC). (Click HERE if you would like to see that analysis.)

There is one change really worth noting:

Quick Analysis: Radient Pharmaceuticals Corp (RPC)

RPC: Radient Pharmaceuticals Corp

Recent Range: $0.25/share - $2.00/share (Current Price: 1.21, as of close of 4/20/10)

Price/Sales (P/S) = 1.17 (35.14, Industry)
Price/Book (P/B) = 0.98 (4.60)
Gross Margin = 46.4% (59.8%)
Pre-Tax Margin = -47.6% (-446.4%)
Debt/Equity Ratio = 0.08 (0.30)
Current Ratio = 0.1 (3.0)
Return on Equity = -34.0% (18.4%)
Return on Assets = -32.8% (8.6%)

Analysis: Based on the numbers, this is not something that I would recommend.